Clinical Trials Browser

Terminated × Interventional × Atypical Squamous Cells of the Cervix × Clear all

NCT03911076 2024-06-17

PVX2

Phase 2 Terminated

Atypical Squamous Cells of the Cervix

NCT03404310 2023-09-22

Zinc Sulfate for Human Papillomavirus (HPV)

Phase NA Terminated

Uterine Cervical Neoplasms, Atypical Squamous Cells of the Cervix

NCT02689726 2016-12-02

Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL

Phase 1 Terminated

Atypical Squamous Cells of the Cervix

NCT00312286 2016-09-23

Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

Phase 2 Terminated

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections, Atypical Squamous Cells of the Cervix